Status:
COMPLETED
LOMA: Long-Term Management of Asthma
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Asthma
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The purpose of this study was to determine whether the use of induced sputum cell counts could guide treatment of asthma more effectively than the use of symptoms and breathing tests. The main outcome...
Detailed Description
Airway inflammation is an important component of asthma. It influences other components which include symptoms and airway functional (physiological) measurements. It is the primary target of treatment...
Eligibility Criteria
Inclusion
- History of asthma for at least one year,confirmed objectively.
- New or previously reviewed patients where the minimal treatment requirements have not been established within the last six months.
Exclusion
- Smokers or ex-smokers for less than 6 months with a smoking history of more than 10 pack years.
- Other pulmonary co-morbidity (other than mild or moderate chronic airflow limitation).
- Subjects having a co-existing illness that precludes them from the study.
- Inability to give informed consent due to mental or legal reasons.
- Pregnancy or lactation.
- Known non-compliance with medications.
Key Trial Info
Start Date :
September 1 1999
Trial Type :
INTERVENTIONAL
End Date :
September 1 2001
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT00182481
Start Date
September 1 1999
End Date
September 1 2001
Last Update
December 16 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Firestone Institute for Respiratory Health, St. Joseph's Healthcare
Hamilton, Ontario, Canada, L8N 4A6